Trial intelligence / Profile preview

Dalcetrapib + Pravastatin in Dyslipidemia

NCT00697203Phase 2Completed

Sponsor
Roche
Start
Jul 2005
Primary completion
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dalcetrapib in dyslipidemia, sponsored by Roche. Started Jul 2005; status: completed.

02

Drugs

dalcetrapib
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT00697203.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00697203.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call